Why is Indrayani Biotec falling/rising?
As of 30-Sep, Indrayani Biotech Ltd's stock price is 12.25, down 2.39%, and has underperformed significantly with a 66.33% decline year-to-date. The stock is facing a bearish trend due to decreasing investor interest and poor performance relative to the broader market.
As of 30-Sep, Indrayani Biotech Ltd's stock price is currently at 12.25, reflecting a decrease of 0.3, or 2.39%. The stock has been underperforming, having lost 6.13% over the last four days, and it has consistently fallen for four consecutive days. Additionally, the stock's performance today has underperformed its sector by 1.18%. In terms of returns, the stock has seen a significant decline of 66.33% year-to-date and 70.06% over the past year, while it has gained 5.79% over the last month. However, the delivery volume has dropped by 58.06% compared to the 5-day average, indicating a decrease in investor participation, which may contribute to the stock's downward trend.Broader market context shows that while the Sensex has declined by 2.23% over the past week, Indrayani Biotech's performance has been worse, with a drop of 5.04%. This suggests that the stock is not only struggling in absolute terms but is also lagging behind the broader market. The stock's moving averages indicate that it is currently higher than the 20-day moving average but lower than the 5-day, 50-day, 100-day, and 200-day moving averages, which may signal a bearish trend. Overall, the combination of declining investor interest, poor recent performance, and significant losses over longer periods suggests a challenging environment for Indrayani Biotech Ltd.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
